PERMIGANAU
ActiveSummary
The annual accounts of PERMIGANAU for financial year 2025 show a net loss of 61% of the equity at the start of that year. The 2025 annual accounts show equity of €1,898 and a net result of -€2,969. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 20% of 784 sector peers (NACE 32, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.0% (low).
Overview
Official details
Source: KBO- Status
- Active since 28-05-2021 Normal situation
- Activity
- Manufacture of medical and dental instruments and supplies NACE 32500and 5 others
- Establishment units
- 2.318.509.737 5190 Jemeppe-sur-Sambre, since 28-05-2021
- 2.357.410.992 5190 Jemeppe-sur-Sambre, since 01-03-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 30-05-2025
Board and ownership
- Permiganau NicolasDirector · since 27-05-2022
- Nicolas PERMIGANAUact of 10-03-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.0%
- Gross margin
- €111,858
- ▲ 131%
- Turnover
- ≈ €280,000
- estimated
- Loss
- €2,969
- ▼ 89.8%
- Equity
- €1,898
- ▼ 61.0%
- Total assets
- €144,620
- ▲ 0.1%
- Staff
- ≈ 2.8 FTE
- estimated
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearFounded in 2021Equity €1,898 (1.3% of total assets)lowers riskSector: Other manufacturing (NACE 32)Size: total assets €144,620Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 19% of them on solvency, 13% on liquidity, 34% on profitability and 9% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 41 days before the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Lower solvency than 80% of companies in other manufacturingsector median 40.8% · 784 companies 1.3% View
- Caution: A director leftlatest change 10-03-2026 · 1 in office 1 left View
- Caution: 2 loss-making years in a rowloss in financial year 2025 -€2,969 View
- Positive: Always filed on timeaccounts within the deadline every year 5 years View
Recent changes
- · Gazette deed Resignation: Aurélie Dumont (director)Transfer of 750 shares from Joyce VAN DER STRAATEN to Nicolas PERMIGANAU · Transfer of 750 shares from Serge KOWALSKI to Nicolas PERMIGANAU · Nicolas PERMIGANAU is a shareholder
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as PERMIGANAU: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €112,000 and €189,000, founded between 2020 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| PERMIGANAU Jemeppe-sur-Sambre | €144,620 | €111,858 |
| SpineTechnics Geel | €155,749 | €102,485 |
| MY OPTIC Sint-Agatha-Berchem | €189,169 | €114,209 |
| Laboratoire dentaire Anne Franck Verlaine | €131,703 | €157,642 |
| Alnilam Dental Kortenberg | €112,117 | €87,192 |
| Dental K Heusden-Zolder | €174,382 | €88,039 |
| LABO JOLY Esneux | €128,942 | €67,193 |
Key facts about PERMIGANAU
- What is the company number of PERMIGANAU?
- The company number of PERMIGANAU is 0768.852.484. The VAT number is the same number with BE in front: BE 0768.852.484.
- Where is PERMIGANAU based?
- The registered office is at Rue Boulanger-Duhayon 9, 5190 Jemeppe-sur-Sambre.Company details
- What does PERMIGANAU do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of PERMIGANAU?
- The legal form of PERMIGANAU is Private limited company (BV).
- When was PERMIGANAU founded?
- PERMIGANAU was founded on 28-05-2021.
- Is PERMIGANAU still active?
- Yes, PERMIGANAU is an active enterprise in the KBO register.
- What is the turnover of PERMIGANAU?
- The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €111,858 and 2,215 comparable companies of the same size. It probably lies between €190,000 and €430,000. It is a rough estimate. In financial year 2021 turnover was €41,176.Financials
- Is PERMIGANAU profitable?
- In financial year 2025, PERMIGANAU made a loss of €2,969.
- Where can I find the annual accounts of PERMIGANAU?
- PERMIGANAU filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PERMIGANAU due?
- PERMIGANAU must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.